Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Perineural inflammatory and immune mediators refer to a complex collection of signaling molecules—including cytokines like TNF-alpha and IL-1 beta, chemokines, and lipid mediators such as prostaglandins—that accumulate around peripheral nerves during injury or infection. These substances collectively form an inflammatory milieu that significantly influences the pharmacodynamics of local anesthetics. One primary mechanism of interference is the induction of local tissue acidosis; because local anesthetics are weak bases, a lower pH increases the ionized fraction of the drug, preventing it from crossing the neuronal lipid bilayer to reach its intracellular target on voltage-gated sodium channels. Additionally, these mediators can directly modulate the expression and gating properties of sodium channels, often leading to a state of hyperexcitability known as peripheral sensitization. This sensitization can result in clinical anesthetic resistance, where standard doses of drugs like lidocaine or bupivacaine fail to provide adequate analgesia. Understanding these interactions is critical for clinical anesthesiology, as the co-administration of anti-inflammatory adjuncts like dexamethasone is often employed to neutralize these mediators and prolong the efficacy of regional nerve blocks.
Local anesthetics primarily inhibit voltage-gated sodium channels to block nerve conduction; however, perineural mediators modulate this effect by altering local pH (acidosis), which reduces anesthetic bioavailability, and by directly sensitizing sodium channels (e.g., Nav1.7, Nav1.8), which can lead to anesthetic resistance.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Perineural inflammatory and immune mediators.